Menu Search
Equities

Aurora Spine Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ASAPF:QBB

Aurora Spine Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.23
  • Today's Change0.011 / 5.02%
  • Shares traded33.70k
  • 1 Year change-19.30%
  • Beta-0.4303
Data delayed at least 15 minutes, as of Feb 10 2026 20:27 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Aurora Spine Corporation is a Canada-based company focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies. The Company’s products generally fall into three product lines: interspinous process (ISP) lumbar fusion devices, Stand-alone (SA) Cervical and Lumbar fusion cages, and SI joint fusion devices. Its ISP lumbar fusion devices include the ZIP, the ZIP ULTR, the ZIP LP and the ZIP-51. It also offers a line of interbody products: Discovery for cervical procedures; SOLO, an ALIF 3D-printed stand-alone lumbar fusion device; SiLO, a posterior allograft implant; and SiLO TFX, a titanium implant device, both for sacroiliac (SI) joint fusion, and Dexa-C a 3D printed cervical fusion device which is paired with the Apollo cervical plate. In addition, the Company markets certain third-party-developed products used during spine surgeries (i.e. surgical screws and bone growth biologic materials).

  • Revenue in CAD (TTM)24.45m
  • Net income in CAD-1.82m
  • Incorporated2013
  • Employees13.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.